Literature DB >> 10385182

Exercise-test Tc-99m tetrofosmin SPECT in patients with chronic ischemic left ventricular dysfunction: direct comparison with Ti-201 reinjection.

E Nicolai1, A Cuocolo, W Acampa, A Varrone, L Pace, M Salvatore.   

Abstract

BACKGROUND: This study was designed to compare the results of exercise-rest technetium-99m tetrofosmin single photon emission computed tomography (SPECT) with those of thallium-201 reinjection at rest after exercise-redistribution imaging in the same patients with chronic ischemic left ventricular (LV) dysfunction.
METHODS: Within 1 week, 33 patients with chronic myocardial infarction and LV dysfunction underwent exercise-rest tetrofosmin SPECT and Tl-201 reinjection at rest after exercise-redistribution imaging. In each patient, regional tetrofosmin and Tl-201 activity was quantitatively measured in 22 myocardial segments. Regional LV function was assessed in corresponding segments by echocardiography.
RESULTS: Agreement in the evaluation of regional perfusion status between tetrofosmin and Tl-201 imaging was observed in 78% of the 726 total segments, with a kappa value of 0.61. In segments with normal function at echocardiography (n = 436), no difference between Tl-201 and tetrofosmin uptake was observed. In hypokinetic segments (n = 138), exercise tetrofosmin uptake was lower (P < .01) as compared with exercise Tl-201 activity, whereas no difference was observed between tetrofosmin uptake at rest as compared with Tl-201 activity on redistribution and reinjection images. In segments with severe functional impairment (akinetic or dyskinetic, n = 152), tetrofosmin uptake on exercise images was reduced (P < .01) as compared with exercise Tl-201 activity; furthermore, tetrofosmin uptake at rest was lower (P < .01) as compared with Tl-201 activity on both redistribution and reinjection images. In these segments, concordance in the detection of myocardial viability between tetrofosmin and Tl-201 imaging was observed in 138 (91%) of the 152 segments, with a kappa value of 0.77.
CONCLUSIONS: In patients with chronic coronary artery disease and LV dysfunction quantitative exercise-rest tetrofosmin and Tl-201 reinjection SPECT provide similar information in the assessment of perfusion status and in the detection of myocardial viability.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10385182     DOI: 10.1016/s1071-3581(99)90038-7

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  27 in total

Review 1.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms.

Authors:  N B Schiller; P M Shah; M Crawford; A DeMaria; R Devereux; H Feigenbaum; H Gutgesell; N Reichek; D Sahn; I Schnittger
Journal:  J Am Soc Echocardiogr       Date:  1989 Sep-Oct       Impact factor: 5.251

2.  Significance of fill-in after thallium-201 reinjection following delayed imaging: comparison with regional wall motion and angiographic findings.

Authors:  N Tamaki; H Ohtani; Y Yonekura; R Nohara; H Kambara; C Kawai; K Hirata; T Ban; J Konishi
Journal:  J Nucl Med       Date:  1990-10       Impact factor: 10.057

3.  Mechanism of uptake of technetium-tetrofosmin. I: Uptake into isolated adult rat ventricular myocytes and subcellular localization.

Authors:  E A Platts; T L North; R D Pickett; J D Kelly
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

4.  Mechanism of uptake of technetium-tetrofosmin. II: Uptake into isolated adult rat heart mitochondria.

Authors:  A Younès; J A Songadele; J Maublant; E Platts; R Pickett; A Veyre
Journal:  J Nucl Cardiol       Date:  1995 Jul-Aug       Impact factor: 5.952

5.  Enhanced detection of viable myocardium by technetium-99m-MIBI imaging after nitrate administration in chronic coronary artery disease.

Authors:  S Maurea; A Cuocolo; A Soricelli; L Castelli; A Nappi; F Squame; M Imbriaco; B Trimarco; M Salvatore
Journal:  J Nucl Med       Date:  1995-11       Impact factor: 10.057

6.  Technetium-99m-tetrofosmin myocardial imaging: a comparison with thallium-201 and angiography.

Authors:  P Rigo; B Leclercq; R Itti; A Lahiri; S Braat
Journal:  J Nucl Med       Date:  1994-04       Impact factor: 10.057

7.  Adenosine technetium-99m-methoxy isobutyl isonitrile myocardial tomography in patients with coronary artery disease: comparison with exercise.

Authors:  A Cuocolo; A Soricelli; L Pace; E Nicolai; L Castelli; A Nappi; M Imbriaco; C Morisco; P J Ell; M Salvatore
Journal:  J Nucl Med       Date:  1994-07       Impact factor: 10.057

8.  Enhanced detection of ischemic but viable myocardium by the reinjection of thallium after stress-redistribution imaging.

Authors:  V Dilsizian; T P Rocco; N M Freedman; M B Leon; R O Bonow
Journal:  N Engl J Med       Date:  1990-07-19       Impact factor: 91.245

9.  Comparison of thallium redistribution with rest "reinjection" imaging for the detection of viable myocardium.

Authors:  T P Rocco; V Dilsizian; K A McKusick; A J Fischman; C A Boucher; H W Strauss
Journal:  Am J Cardiol       Date:  1990-07-15       Impact factor: 2.778

10.  Exercise echocardiography and technetium-99m MIBI single-photon emission computed tomography in the detection of coronary artery disease.

Authors:  M M Pozzoli; P M Fioretti; A Salustri; A E Reijs; J R Roelandt
Journal:  Am J Cardiol       Date:  1991-02-15       Impact factor: 2.778

View more
  3 in total

1.  The role of cardiac imaging in optimizing therapy in heart failure.

Authors:  A Lahiri
Journal:  J Nucl Cardiol       Date:  2000 Jan-Feb       Impact factor: 5.952

2.  Tetrofosmin imaging in the detection of myocardial viability in patients with previous myocardial infarction: comparison with sestamibi and Tl-201 scintigraphy.

Authors:  Wanda Acampa; Alberto Cuocolo; Mario Petretta; Andrea Bruno; Massimo Castellani; Andrea Finzi; Paolo Gerundini
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

3.  PGC-1α Promoter Methylation in Parkinson's Disease.

Authors:  Xiaomin Su; Yaping Chu; Jeffrey H Kordower; Bin Li; Hong Cao; Liang Huang; Maki Nishida; Lei Song; Difei Wang; Howard J Federoff
Journal:  PLoS One       Date:  2015-08-28       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.